Could grant funding be the key to unlocking your business’s growth without giving away equity?
In this episode of Finance Focus, hosts Sam Jones and Tracy Smart sit down with Paul Finn, Chief Scientific Officer at Oxford Drug Design, to uncover the secrets of securing non-dilutive funding. With over $10 million successfully raised through grants, Paul shares expert insights into the application process, the challenges of bureaucracy, and how businesses can improve their chances of winning funding.
Whether you’re a startup or an established company, this episode is packed with practical advice on how to navigate the grant funding landscape effectively.
Paul Finn: Chief Scientific Officer at Oxford Drug Design, with extensive experience in securing grant funding for biotech and pharmaceutical research. He has successfully raised over $10 million in non-dilutive funding and also serves as a grant assessor, reviewing applications for funding bodies across the UK, EU, and the US.
Finance Focus helps businesses navigate the ever-evolving world of finance. Each episode features expert insights, practical advice, and in-depth discussions on topics such as crowdfunding, trade finance, angel investing and debt. Hosted by Tracy Smart from The Smart Team and Sam Jones from Satellite Finance.
Connect with Tracy on LinkedIn
Connect with Sam on LinkedIn
Finance Focus is produced and edited by Story Ninety-Four in Oxford.